• Record sample volumes processed in March and April 2026
• 19 new PhotonAssay lease agreements signed, including with ALS and Bureau Veritas
• On track to achieve FY26 guidance for revenue and EBITDA

Chrysos Corporation Ltd (ASX:C79) has provided a trading update, highlighting several key achievements. In March 2026, the company achieved a new fleet record, processing over one million samples in a single month, followed by a second consecutive month exceeding one million samples in April. These record sample volumes underscore the growing productivity and utilization of the deployed PhotonAssay network, which is a key revenue and profitability driver for the company.Chrysos has also continued to expand its international footprint, signing 19 new PhotonAssay lease agreements since the last update, including five new contracts. This includes further agreements with ALS, with sixteen units now within that growing partnership, as well as a second lease agreement with Bureau Veritas for deployment in Australia.The company is also continuing to grow its direct-to-mine presence, with an expansion of the relationship with Allied Gold, including a lease agreement for their Kurmuk mine site in Ethiopia, as well as an additional miner-contracted unit for deployment later in the calendar year.Chrysos is on track to achieve its FY26 guidance, with revenue tracking at the upper end of the $80m to $90m range and EBITDA tracking at the upper end of the $20m to $27m range. The company is also progressing its previously announced refinancing to a total level of $200 million, which is expected to be completed before 30 June 2026.

Revenue is tracking at the upper end of the $80m to $90m guidance range. EBITDA is tracking at the upper end of the $20m to $27m guidance range.